Actual aspects of diagnostic and treatment of pituitary diseases.
The event will be held in a hybrid format. The programme includes sponsored lectures

25 February 2022 / Friday


14:20 - 14:30 (CET)
Opening ceremony

Session I
14:30 - 15:55 (CET)
Aggressive pituitary tumours  (85 minutes)

  • 14:30 - 14:55 (CET)
    Aggressive pituitary tumours –how to diagnose and proceed 
    Prof. Gerald Raverot 
  • 14:55 - 15:20 (CET)
    Genetics of Cushing's Disease
    Prof. Marta Korbonits
  • 15:20 - 15:45 (CET)
    Aggressive non-functioning pituitary tumours 
    Prof. Niki Karavitaki
  • 15:45 - 15:55 (CET)
    Q & A  Discussion

Expert lecture of the National Consultant in Endocrinology 

15:55 - 16:15

National Program of Growth Hormone Deficiency Treatment in Adults Prof. Andrzej Lewiński


Session II
16:15 - 17:15 (CET)
Treatment with Growth Hormone in the transition age for young adults and adult patients (60 minutes)

  • Modyfikacja leczenia substytucyjnego w okresie dorastania/ u młodych dorosłych Dr hab. Małgorzata Wójcik
  • Powikłania metaboliczne i zasady farmakoterapii u pacjentów z niedoczynnością przysadki  Dr hab. Anna Popławska-Kita 
  • Practical aspects and experiences in qualification and treatment of patients for National Program of Growth Hormone Deficiency Treatment in Adults Dr hab. Renata Stawerska
  • Q&A- Discussion


Session III
17:15 - 18:55 (CET)

Diagnostic standards and treatment of acromegaly (100 minutes)


  • Current acromegaly management guidelines Prof. Alicja Hubalewska-Dydejczyk 
  • What we know about acromegaly in Poland? Prof. Wojciech Zgliczyński
  • Acromegaly complications - The diagnosis and treatment  Prof. Marek Ruchała
  • Improvement of quality of life in patients with acromegaly during treatment Prof. Marek Bolanowski
  • Management of patients with aggressive tumours in acromegaly Dr hab. Aleksandra Gilis-Januszewska, Prof. UJ 
  • Q&A- Discussion


Session IV
18:55 - 19:35 (CET)
Acromegaly- presentation of challenging cases (40 minutes)

  • TBA
  • Silent GH Magdalena Godlewska, MD
  • Young Onset Acromegaly TBA
  • Long-term experience of Somnavert as a treamtet of acomegaly Jacek Pantofliński, MD, PhD
  • Q&A- Discussion



26 February 2022 / Saturday

Session V
9:00 - 10:40 (CET)
Cushing syndrome - Diagnostic standards and treatment (100 minutes)


  • The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing syndrome Prof. Grzegorz Zieliński
  • The diagnosis of Cushing syndrome - current Pituitary Society guidelines Dr hab. A.Gilis-Januszewska Prof. UJ
  • Management of arterial hypertension in Cushing disease  Prof. Przemysław Witek
  • Thromboembolic complication in hypercortisolism Joanna Zdziarska, MD, PhD
  • Cyclical Cushing syndrome Dr hab. Renata Świątkowska-Stodulska
  • Q&A- Discussion



Session VI
10:40 - 11:20 (CET)
Cushing syndrome - cases presentation (40 minutes)

  • Pituitary carcinoma and liver metastases in a patient with Cushing disease Maria Stelmachowska-Banaś, Md, PhD
  • Temozolomide and pasireotide treatment in a patient with aggressive silent corticotrophinoma Anna Bogusławska, MD
  • Young patient with Cushing disease and glucocorticoids resistance Ewa Obel, MD, PhD
  • Q&A- Discussion



Session VII
11:20 - 13:00 (CET)

Craniopharyngioma in children and adults (100 minutes)

  • Craniopharyngioma in children Prof. Jerzy Starzyk
  • Craniopharyngioma in adults Łukasz Kluczyński MD, PhD
  • Surgical management of craniopharyngioma Borys Kwinta MD, PhD
  • Metabolic complications - pharmacologic treatment of obesity Prof. Beata Matyjaszek-Matuszek
  • Obesity treatment in patients with craniopharyngioma Prof. Piotr Major 
  • TBA  Bartosz Partyński MD
  • Q&A- Discussion


13.00 - 15.00 (CET) Lunch


Session VIII
15:30 - 16:30 (CET)
he genetics of pituitary tumours. Presentation of challenging cases (60 minutes)

  • McCune-Albright syndrome Prof. Katarzyna Ziemnicka 
  • Carney complex Maria Stelmachowska-Banaś, MD, PhD
  • Pituitary adenoma and pheochromocytoma/paraganglioma association. Heterogeneity of clinical course of the disease with various genetic mutations  Ewelina Rzepka MD
  • MEN1/MEN4 Anna Bogusławska, MD
  • Q&A- Discussion


Session IX
16:30 - 17:50 (CET)
Perioperative management of patients with pituitary tumours (80 minutes)

  • Diagnostic and treatment of diabetes insipidus Prof. Anhelli Syrenicz
  • Management of perioperative electrolyte imbalance Dr hab. Dariusz Kajdaniuk
  • Treatment of central hypothyroidism in a challenging cases Prof. Alicja Hubalewska-Dydejczyk
  • Treatment of insufficiency of pituitary adrenal axis is an art Prof. Tomasz Bednarczuk